Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Actinogen presents positive Phase 2a Xanamem data in at ADPD™ Alzheimer's and Parkinson's diseases conference 2023-03-30 21:00
Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production Platform 2023-03-30 20:00
ACROBiosystems' new strategic focus - streamlining the transition from preclinical development to commercialization 2023-03-30 18:54
Zylox-Tonbridge Announces Financial Results for 2022: Revenue Increases by 87.8% YOY to RMB 334 million and Gross Profit Reaches RMB 253 million 2023-03-30 15:49
ImmVira's oncolytic product MVR-C5252 targeting malignant glioma obtained NMPA's approval for Clinical Trial in China 2023-03-30 08:00
bitBiome and Kaken Pharmaceuticals sign joint research agreement on the discovery of drugs for infectious diseases 2023-03-29 22:00
CHINA LIFE INSURANCE COMPANY LIMITED ANNOUNCES 2022 ANNUAL RESULTS (H SHARES) 2023-03-29 21:22
Scivita Medical enters into Strategic Agreement with Boston Scientific in China 2023-03-29 21:08
Just Three Months Into 2023, United Imaging Says Four New Scanners in Multiple Imaging Modalities Are Now Commercially Available in the United States 2023-03-29 21:00
HanAll Biopharma Assigns Su-jin Park as Co-CEO to Drive Next Phase of Growth 2023-03-29 19:00
Fosun Pharma Announces its 15th Corporate Social Responsibility Report: Continuous Innovation for the Benefit of the Public 2023-03-29 14:06
Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China 2023-03-28 21:41
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award 2023-03-28 20:00
Tigermed Reports Full Year 2022 Results 2023-03-28 19:09
Fosun Pharma Announces 2022 Annual Results: Achieved Steady Growth with Revenue from Record High Innovative Products and Global Commercialization Capability Improvement 2023-03-28 16:20
OncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab 2023-03-28 15:36
Acepodia to Present Preclinical Data of Gamma Delta T cell Therapy Candidate, ACE2016, an off-the-shelf EGFR-targeting γδ2 T cell therapy against EGFR-expressing solid tumors 2023-03-28 10:00
BJ Bioscience Announces Clinical Collaboration with MSD to Evaluate BJ-001 in Combination with KEYTRUDA® (pembrolizumab) 2023-03-28 09:19
Noul Co. Ltd - The RIGHT Foundation Commences Research and Development for Supporting Malaria Control 2023-03-27 21:00
Berry Genomics and Ajlan & Bros Holding Subsidiaries Establish a Joint Venture to Support 'Vision 2030' 2023-03-27 20:46
1 107 108 109 110 111 801